The National Pharmaceutical Pricing Authority (NPPA) committee the suggested the retail price of each uncoated tablet containing Dexamethasone IP 6 mg for Cadila Healthcare Ltd (manufacturer) and Zydus healthcare Ltd (marketers) as Rs.3.36 per tablet excluding GST.
The recommendation was made by the multidisciplinary committee of experts at the 31st meeting held on April 27 2012. The issue of the retail price fixation of each uncoated tablet containing dexamethasone IP 6 mg manufactured by Cadila Healthcare Ltd. and marketed by Zydus healthcare Ltd. under para 5 of the DPCO, 2013 was addressed during the meeting.
Dexamethasone a type of corticosteroid medication that has anti-immunosuppressant effects and is widely used in rheumatic disorders, skin related disorders, etc.
Dexamethasone is also recommended by the national health in the UK and the national institute of health (NIH) in the US for patients who are suffering from severe COVID – 19 and need either mechanical ventilation or supplement oxygen (without ventilation). Dexamethasone is otherwise not suggested.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…